BRD4 and hepatocellular carcinoma: Lin et al. employed ChIP-seq to demonstrate that AZD5153 (a bifunctional BRD4 inhibitor) significantly reduces BRD4 binding at super-enhancers (SEs), promoters, and gene bodies in HCC cells (Lin et al., 2022).